(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REXULTI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REXULTI

ST13

US500000079114561

Class

5

Filing

79114561

Registration

4287396

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

02/20/2026

Trademark type

Word

Nice classes

5

Filing date

03/26/2012

Registration date

02/12/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/21/2023

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

Tokyo, JP

Examiner

CAPSHAW, DANIEL

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Otsuka Pharmaceutical Co., Ltd.
H. Lundbeck A/S

Representatives

Scott S. Havlick Holland & Hart LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's diseasedepressionpsychosisanxietyepilepsysclerosisporphyriesHuntington's diseaseinsomniaParkinson diseaseschizophreniabipolar disorderoncologypainalcoholism and dependency; diagnostic preparationssubstancesreagents and agents for medical purposes

Publications

History of USPTO decisions and trademark events.

49 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/19/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/29/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/21/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/21/2023

71AG

REGISTERED-SEC.71 ACCEPTED

07/21/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/18/2023

ES71

TEAS SECTION 71 RECEIVED

01/02/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/14/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/12/2022

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

01/03/2020

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

11/18/2019

INPC

INVALIDATION PROCESSED

11/18/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

10/26/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/26/2019

71AG

REGISTERED-SEC.71 ACCEPTED

02/26/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/08/2019

ES71

TEAS SECTION 71 RECEIVED

02/01/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/12/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/20/2015

DCPN

CHANGE OF OWNER RECEIVED FROM IB

08/20/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2014

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/15/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/23/2013

FIMP

FINAL DISPOSITION PROCESSED

09/23/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/12/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

02/12/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/27/2012

PUBO

PUBLISHED FOR OPPOSITION

11/27/2012

GPNX

NOTIFICATION PROCESSED BY IB

11/26/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/07/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/07/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/07/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/24/2012

ALIE

ASSIGNED TO LIE

10/22/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/09/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/05/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/04/2012

RFNP

REFUSAL PROCESSED BY IB

09/09/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/27/2012

RFRR

REFUSAL PROCESSED BY MPU

07/27/2012

MAFR

APPLICATION FILING RECEIPT MAILED

07/27/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/26/2012

CNRT

NON-FINAL ACTION WRITTEN

07/25/2012

DOCK

ASSIGNED TO EXAMINER

07/23/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/23/2012

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/20/2012

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/19/2012

Continuous trademark protection

Get notified about every new filing that threatens REXULTI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.